Premium Quality Alexa Fluor® 647 Anti-human Cd307c/fcrl3 Instant 75% Discount [owVjmegB]

Alexa Fluor® 647 Anti-Human CD307c/FcRL3

The Alexa Fluor® 647 Anti-Human CD307c/FcRL3 is a highly specialized monoclonal antibody designed for immunological research. This antibody is engineered to recognize and bind to CD307c, a type 1 transmembrane glycoprotein in the FcRL family. CD307c is uniquely expressed on various immune cell subsets, making it an essential target for studying immune response regulation and autoimmune diseases. The antibody's exceptional specificity and affinity provide researchers with a powerful tool for investigating the complex interplay between immune cells and their functions.

Product Specifications and Benefits

This antibody is produced using the H5/FcRL3 clone, offering a high level of purity and consistency. It is formatted in Alexa Fluor 647, a vibrant and bright fluorophore that enhances the visibility of immunofluorescence assays. The antibody is of mouse origin and isotype IgG2b, κ, ensuring compatibility with a wide range of immunological applications. Key features include:

High Specificity: Recognizes human CD307c with high affinity, minimizing cross-reactivity with other antigens.

Multi-Application Potential: Suitable for flow cytometry, immunohistochemistry, and other immunological techniques.

The regulatory status of this product is RUO (Research Use Only), making it ideal for academic and research settings.

Applications and Target Audience

The Alexa Fluor® 647 Anti-Human CD307c/FcRL3 is a versatile reagent that finds extensive use in immunological research. Its ability to target CD307c, a glycoprotein associated with immune regulation and autoimmune diseases, makes it particularly valuable for studies on systemic lupus erythematosus, rheumatoid arthritis, and autoimmune thyroid disease. Researchers in immunology, oncology, and inflammation will benefit greatly from this antibody, as it allows for the detailed analysis of immune cell subsets and their roles in various pathologies. By providing a clear and accurate marker for CD307c, this antibody empowers scientists to advance their understanding of immune responses and develop potential therapeutic strategies.